Etomidate Versus Propofol in CABG Surgery
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.
Also called NCT06068764
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose supportive care
- Phase
- Phase 4
- Enrolled
- 300 participants
- Sponsor
- Registry
-
NCT06068764
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Unknown status
Technical summary
Registry record NCT06068764. Randomized; single masking; primary purpose supportive care. Start 2023-12-05 (actual); primary completion 2025-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Etomidate Versus Propofol in CABG Surgery
- Acronym
- ETOPRO
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Etomidate
- Intervention (Drug)
- Propofol
- Lead sponsor
- Hartford Hospital
Record details
- Record id
cardio:ct-nct06068764- Content hash
e3eb981ff033cfa8d04d71a60581db85444160fb43ce7e0c9bb866c4b244be76